Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19

The vaccine did better at preventing disease in this country – 72% percent — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%.

Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19 The vaccine did better at preventing disease in this country – 72% percent — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%. Read More You received this message because you're subscribed to Breaking News Alerts emails. This email was sent by National Public Radio, Inc., 1111 North Capitol Street NE, Washington, DC 20002 Unsubscribe  |  Privacy Policy